top of page
Cardiovascular disease accounts for nearly 1 in 3 deaths globally, remaining the primary global cause of mortality. Around 80% of them are due to stroke and heart attacks. This “silent killer”, both chronic and asymptomatic in numerous patients, remains a particular challenge for doctors and the pharmaceutical industry despite the large number of existing drugs.
bottom of page